{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T09:45:09Z","timestamp":1785750309415,"version":"3.56.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23\\u202FK05538"],"award-info":[{"award-number":["23\\u202FK05538"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20\\u202FK06434"],"award-info":[{"award-number":["20\\u202FK06434"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bcp.2025.116894","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T18:02:22Z","timestamp":1743184942000},"page":"116894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exploration of functional cytochrome P450 4F enzymes in liver, intestine, and kidney from dogs, cats, pigs, and tree shrews and comparison of their metabolic capacities with human P450 4F2 and 4F12"],"prefix":"10.1016","volume":"236","author":[{"given":"Yasuhiro","family":"Uno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genki","family":"Ushirozako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Tsukiyama-Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazuki","family":"Mizukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norie","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcp.2025.116894_b0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1538\/expanim.63.367","article-title":"Tupaia belangeri as an experimental animal model for viral infection","volume":"63","author":"Tsukiyama-Kohara","year":"2014","journal-title":"Exp Anim"},{"issue":"3","key":"10.1016\/j.bcp.2025.116894_b0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1034\/j.1600-0684.2003.00022.x","article-title":"The tree shrews: adjuncts and alternatives to primates as models for biomedical research","volume":"32","author":"Cao","year":"2003","journal-title":"J Med Primatol"},{"issue":"1","key":"10.1016\/j.bcp.2025.116894_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-200401000-00001","article-title":"Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants","volume":"14","author":"Nelson","year":"2004","journal-title":"Pharmacogenetics"},{"issue":"1","key":"10.1016\/j.bcp.2025.116894_b0020","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0003-9861(02)00511-8","article-title":"Expression of CYP4F8 (prostaglandin H 19-hydroxylase) in human epithelia and prominent induction in epidermis of psoriatic lesions","volume":"409","author":"Stark","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.bcp.2025.116894_b0025","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1006\/bbrc.2000.4191","article-title":"cDNA cloning and expression of CYP4F12, a novel human cytochrome P450","volume":"280","author":"Bylund","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"41","key":"10.1016\/j.bcp.2025.116894_b0030","doi-asserted-by":"crossref","first-page":"38166","DOI":"10.1074\/jbc.M104818200","article-title":"Alternative splicing determines the function of CYP4F3 by switching substrate specificity","volume":"276","author":"Christmas","year":"2001","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.bcp.2025.116894_b0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/geno.2000.6276","article-title":"A novel human cytochrome P450 4F isoform (CYP4F11): cDNA cloning, expression, and genomic structural characterization","volume":"68","author":"Cui","year":"2000","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/j.bcp.2025.116894_b0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/mi.11.2.10","article-title":"Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states","volume":"11","author":"Kelly","year":"2011","journal-title":"Mol. Interv."},{"issue":"2","key":"10.1016\/j.bcp.2025.116894_b0045","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jdermsci.2011.12.006","article-title":"CYP4F22 is highly expressed at the site and timing of onset of keratinization during skin development","volume":"65","author":"Sasaki","year":"2012","journal-title":"J Dermatol Sci"},{"issue":"2\u20133","key":"10.1016\/j.bcp.2025.116894_b0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/03602530701468573","article-title":"Human cytochrome p450 family 4 enzymes: function, genetic variation and regulation","volume":"39","author":"Hsu","year":"2007","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bcp.2025.116894_b0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/bs.apha.2015.05.002","article-title":"Cytochrome P450 omega-Hydroxylases in Inflammation and Cancer","volume":"74","author":"Johnson","year":"2015","journal-title":"Adv Pharmacol"},{"issue":"2","key":"10.1016\/j.bcp.2025.116894_b0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1124\/dmd.110.035378","article-title":"CYP4F enzymes are responsible for the elimination of fingolimod (FTY720), a novel treatment of relapsing multiple sclerosis","volume":"39","author":"Jin","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.bcp.2025.116894_b0065","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1124\/dmd.107.016428","article-title":"Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine","volume":"35","author":"Wang","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.bcp.2025.116894_b0070","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/jpet.300.1.298","article-title":"Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes","volume":"300","author":"Hashizume","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.bcp.2025.116894_b0075","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1124\/dmd.114.059626","article-title":"Characterization of the active site properties of CYP4F12","volume":"42","author":"Eksterowicz","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2025.116894_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.06.008","article-title":"Utility of non-human primates in drug development: Comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes","volume":"121","author":"Uno","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.bcp.2025.116894_b0085","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/03602532.2010.549492","article-title":"Macaque cytochromes P450: nomenclature, transcript, gene, genomic structure, and function","volume":"43","author":"Uno","year":"2011","journal-title":"Drug Metab Rev"},{"issue":"1","key":"10.1016\/j.bcp.2025.116894_b0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.abb.2007.07.003","article-title":"Characterization of cynomolgus monkey cytochrome P450 (CYP) cDNAs: Is CYP2C76 the only monkey-specific CYP gene responsible for species differences in drug metabolism?","volume":"466","author":"Uno","year":"2007","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"10.1016\/j.bcp.2025.116894_b0095","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/dmd.116.070367","article-title":"A New Marmoset P450 4F12 Enzyme Expressed in Small Intestines and Livers Efficiently Metabolizes Antihistaminic Drug Ebastine","volume":"44","author":"Uehara","year":"2016","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.bcp.2025.116894_b0100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1292\/jvms.10-0333","article-title":"Cynomolgus macaque CYP4 isoforms are functional, metabolizing arachidonic acid","volume":"73","author":"Uno","year":"2011","journal-title":"J Vet Med Sci"},{"issue":"4","key":"10.1016\/j.bcp.2025.116894_b0105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1124\/dmd.123.001603","article-title":"Novel Tree Shrew Cytochrome P450 2Ds (CYP2D8a and CYP2D8b) Are Functional Drug-Metabolizing Enzymes that Metabolize Bufuralol and Dextromethorphan","volume":"52","author":"Ushirozako","year":"2024","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.bcp.2025.116894_b0110","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1124\/dmd.122.000930","article-title":"Cytochrome P450 2J Genes Are Expressed in Dogs, Cats, and Pigs, and Encode Functional Drug-Metabolizing Enzymes","volume":"50","author":"Uno","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.bcp.2025.116894_b0115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1124\/mol.106.022673","article-title":"CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone","volume":"70","author":"Uno","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"8","key":"10.1016\/j.bcp.2025.116894_b0120","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0006-2952(97)00643-6","article-title":"High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli","volume":"55","author":"Iwata","year":"1998","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"10.1016\/j.bcp.2025.116894_b0125","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/00498254.2016.1206673","article-title":"Marmoset cytochrome P450 4A11, a novel arachidonic acid and lauric acid omega-hydroxylase expressed in liver and kidney tissues","volume":"47","author":"Uehara","year":"2017","journal-title":"Xenobiotica"},{"issue":"4","key":"10.1016\/j.bcp.2025.116894_b0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/00498254.2017.1321811","article-title":"Terfenadine t-butyl hydroxylation catalyzed by human and marmoset cytochrome P450 3A and 4F enzymes in livers and small intestines","volume":"48","author":"Uehara","year":"2018","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2025.116894_b0135","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1073\/pnas.88.13.5597","article-title":"Expression and enzymatic activity of recombinant cytochrome P450 17\u03b1-hydroxylase in Escherichia coli","volume":"88","author":"Barnes","year":"1991","journal-title":"Proc.nat.acad.sci USA"},{"key":"10.1016\/j.bcp.2025.116894_b0140","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1016\/S0021-9258(19)73803-4","article-title":"Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies","volume":"237","author":"Phillips","year":"1962","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2025.116894_b0145","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","article-title":"The Carbon Monoxide-Binding Pigment of Liver Microsomes. I. Evidence for Its Hemoprotein Nature","volume":"239","author":"Omura","year":"1964","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.bcp.2025.116894_b0150","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1124\/dmd.124.001780","article-title":"Investigation of functional cytochrome P450 4A enzymes in liver and kidney of pigs, cats, tree shrews, and dogs in comparison with the metabolic capacity of human P450 4A11","volume":"52","author":"Uno","year":"2024","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.bcp.2025.116894_b0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0021-9258(18)48462-1","article-title":"Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences","volume":"267","author":"Gotoh","year":"1992","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.bcp.2025.116894_b0160","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1124\/dmd.114.058040","article-title":"The revised human liver cytochrome P450 \u201cPie\u201d: absolute protein quantification of CYP4F and CYP3A enzymes using targeted quantitative proteomics","volume":"42","author":"Michaels","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.bcp.2025.116894_b0165","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.pharmthera.2006.03.008","article-title":"Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism","volume":"112","author":"Kalsotra","year":"2006","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.bcp.2025.116894_b0170","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2133\/dmpk.20.478","article-title":"Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs","volume":"20","author":"Imaoka","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"issue":"4","key":"10.1016\/j.bcp.2025.116894_b0175","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/nar\/gkn1047","article-title":"Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytes","volume":"37","author":"Hariparsad","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.bcp.2025.116894_b0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/dmd.111.041178","article-title":"Regulation of cytochrome P450 4F11 by nuclear transcription factor-\u03baB","volume":"40","author":"Bell","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.bcp.2025.116894_b0185","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1074\/jbc.M608176200","article-title":"Regulation of human cytochrome P450 4F2 expression by sterol regulatory element-binding protein and lovastatin","volume":"282","author":"Hsu","year":"2007","journal-title":"J Biol Chem"},{"issue":"25","key":"10.1016\/j.bcp.2025.116894_b0190","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1073\/pnas.1503491112","article-title":"Essential role of the cytochrome P450 CYP4F22 in the production of acylceramide, the key lipid for skin permeability barrier formation","volume":"112","author":"Ohno","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"30","key":"10.1016\/j.bcp.2025.116894_b0195","doi-asserted-by":"crossref","first-page":"21191","DOI":"10.1074\/jbc.274.30.21191","article-title":"Expression of the CYP4F3 gene. tissue-specific splicing and alternative promoters generate high and low K(m) forms of leukotriene B(4) omega-hydroxylase","volume":"274","author":"Christmas","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2025.116894_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpc.2022.109534","article-title":"Novel cytochrome P450 1 (CYP1) genes in tree shrews are expressed and encode functional drug-metabolizing enzymes","volume":"265","author":"Uno","year":"2023","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"issue":"5","key":"10.1016\/j.bcp.2025.116894_b0205","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/dmd.122.001152","article-title":"Newly Identified Tree Shrew Cytochrome P450 2A13 is Expressed in Liver and Lung and Encodes a Functional Drug-Metabolizing Enzyme Similar to Dog Cytochrome P450 2A13 and Pig Cytochrome P450 2A19","volume":"51","author":"Ushirozako","year":"2023","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.bcp.2025.116894_b0210","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/00498254.2022.2141153","article-title":"Newly identified tree shrew cytochrome P450 2B6 (CYP2B6) and pig CYP2B6b are functional drug-metabolising enzymes","volume":"52","author":"Uno","year":"2022","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2025.116894_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpc.2023.109579","article-title":"Newly identified cytochrome P450 3A genes of tree shrews and pigs are expressed and encode functional enzymes","volume":"267","author":"Uno","year":"2023","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"issue":"10\u201311","key":"10.1016\/j.bcp.2025.116894_b0220","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/00498254.2023.2280996","article-title":"Tree shrew cytochrome P450 2E1 is a functional enzyme that metabolises chlorzoxazone and p-nitrophenol","volume":"53","author":"Ushirozako","year":"2023","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2025.116894_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115990","article-title":"Identification of cytochrome P450 2C18 and 2C76 in tree shrews: P450 2C18 effectively oxidizes typical human P450 2C9\/2C19 chiral substrates warfarin and omeprazole with less stereoselectivity","volume":"228","author":"Uno","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"5 Pt 2","key":"10.1016\/j.bcp.2025.116894_b0230","first-page":"H2098","article-title":"Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels","volume":"266","author":"Harder","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bcp.2025.116894_b0235","doi-asserted-by":"crossref","unstructured":"D. Gebremedhin, A.R. Lange, J. Narayanan, M.R. Aebly, E.R. Jacobs, D.R. Harder, Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current, J Physiol 507 (Pt 3)(Pt 3) (1998) 771-781.","DOI":"10.1111\/j.1469-7793.1998.771bs.x"},{"issue":"2","key":"10.1016\/j.bcp.2025.116894_b0240","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.abb.2005.07.003","article-title":"Oxygenation of polyunsaturated long chain fatty acids by recombinant CYP4F8 and CYP4F12 and catalytic importance of Tyr-125 and Gly-328 of CYP4F8","volume":"441","author":"Stark","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.bcp.2025.116894_b0245","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.taap.2003.12.033","article-title":"Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids","volume":"199","author":"Kalsotra","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2025.116894_b0250","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.bcp.2025.116894_b0255","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1152\/physiolgenomics.00003.2007","article-title":"Functional polymorphism in human CYP4F2 decreases 20-HETE production","volume":"30","author":"Stec","year":"2007","journal-title":"Physiol Genomics"},{"issue":"2","key":"10.1016\/j.bcp.2025.116894_b0260","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/HYPERTENSIONAHA.108.114199","article-title":"The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure","volume":"52","author":"Fava","year":"2008","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.bcp.2025.116894_b0265","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/HYPERTENSIONAHA.107.104463","article-title":"A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure","volume":"51","author":"Ward","year":"2008","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.bcp.2025.116894_b0270","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/clpt.2009.223","article-title":"Genetic and clinical predictors of warfarin dose requirements in African Americans","volume":"87","author":"Cavallari","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.bcp.2025.116894_b0275","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2133\/dmpk.DMPK-10-RG-080","article-title":"Influence of CYP4F2 rs2108622 (V433M) on warfarin dose requirement in Asian patients","volume":"26","author":"Singh","year":"2011","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"10.1016\/j.bcp.2025.116894_b0280","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2011.11.043","article-title":"Influence of CYP4F2 genotype on warfarin dose requirement-a systematic review and meta-analysis","volume":"130","author":"Liang","year":"2012","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.bcp.2025.116894_b0285","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2007-11-122010","article-title":"CYP4F2 genetic variant alters required warfarin dose","volume":"111","author":"Caldwell","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2025.116894_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116124","article-title":"A variety of cytochrome P450 enzymes and flavin-containing monooxygenases in dogs and pigs commonly used as preclinical animal models","volume":"228","author":"Uno","year":"2024","journal-title":"Biochem Pharmacol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500156X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500156X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:38:51Z","timestamp":1777401531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522500156X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":58,"alternative-id":["S000629522500156X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116894","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of functional cytochrome P450 4F enzymes in liver, intestine, and kidney from dogs, cats, pigs, and tree shrews and comparison of their metabolic capacities with human P450 4F2 and 4F12","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116894"}}